Search

  Advanced Search

Emergency Information for ICE Employees

Hurricane Graphic

In Focus

IMAGE Program

Info Updates

National Threat Advisory

Elevated

threat advisory
Significant Risk of Terrorist Attacks

Report Suspicious Activity:

1-866-DHS-2-ICE
1-866-347-2423

Information for families of ICE detainees:

Contact Information

Public Information


The Cornerstone Report: Volume 2, Issue 1

Stopping The Flow Of Counterfeit Drugs

Photo of a bottle of counterfeit viagra next to a bottle of genuine viagra.



    Red Flag Indicators

    Flag iconFrequent and unusual use of
    money orders in business transactions.

    Flag iconCommingling of business and
    personal funds in bank accounts.

Driving a silver Porsche 911 and dining on $1,000 dinners with his girlfriend, Mark Kolowich of San Diego presented himself as a savvy businessman who had made a fortune selling Viagra and other prescription drugs over the Internet.

But in reality, he was the organizer of one of the nation’s largest criminal operations for trafficking in counterfeit pharmaceuticals.

On January 21, 2005, a federal judge in San Diego sentenced Kolowich to serve 51 months in prison and to forfeit substantial cash proceeds associated with his criminal enterprise.

A total of 16 defendants from California, Florida, Mexico and the Bahamas were charged as the result of a cooperative investigation involving ICE and a number of other federal and local agencies.

This case illustrates that counterfeit pharmaceuticals have emerged as a big business—and one which criminal organizations are prepared to exploit for profit.

These sales represent a serious liability for the pharmaceutical industry and its investors, as well as to the American people, who contribute millions of tax dollars each year to research, develop and test new drugs.

Furthermore, patients also are potential victims of this dangerous form of counterfeiting crime, since fake drugs don’t adhere to standards for safety and effectiveness. The quality and potency of these fake drugs—often produced in overseas facilities that aren’t regulated by U.S. health and safety standards—isn’t guaranteed.

The bottom line is that while the U.S. pharmaceutical supply remains the safest in the world, the infusion of counterfeit drugs into the supply line could serve to compromise consumer safety. Consumers, health care professionals and business leaders should be aware of the threats posed by fake drugs.

For more on ICE intellectual property investigations, visit us online at www.ice.gov.

Back to Top

INSIDE THIS ISSUE
E-MAIL SIGN UP

COMMENTS / CONTRIBUTIONS
Report Suspicious Activity:
1-866-DHS-2-ICE

  Last Modified: